enVVeno Medical Growth Metrics (2018-2020) | NVNO

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Sep2020 Dec2020
Growth Ratios
Assets Growth (1y) 0.66%5.81%-3.52%-49.53%22.45%
Assets (QoQ) -24.56%-34.52%54.18%32.16%-20.70%-40.29%-19.35%
Capital Expenditures Growth (1y) 215.79%195.17%112.55%
Capital Expenditures (QoQ) -56.13%9,746.11%-3.01%-92.46%-59.00%
Cash & Equivalents Growth (1y) 790.41%-24.86%-29.74%-52.30%-73.84%91.24%
Cash & Equivalents (QoQ) 1,822.31%-29.50%-34.58%0.43%62.23%-34.08%-55.59%-44.91%
Cash from Investing Activities Growth (1y) -215.79%-195.17%-112.55%
Cash from Investing Activities (QoQ) 56.13%-9,746.11%3.01%92.46%59.00%
Cash from Operations Growth (1y) 8.11%7.23%22.62%-12.36%22.86%-61.02%
Cash from Operations (QoQ) 5.19%-13.21%17.19%-3.38%4.28%5.57%-20.24%29.02%
EBITDA Margin Growth (1y) -0.04M
EBITDA Margin (QoQ) 0.10M0.02M-0.23M0.08M
EBIT Growth (1y) -8.64%37.02%-23.28%-27.80%
EBIT Margin Growth (1y) -0.04M
EBIT Margin (QoQ) 0.10M0.02M-0.23M0.08M
EBIT (QoQ) -113.66%52.19%-20.92%12.04%-23.86%6.42%-25.35%
EBT Growth (1y) -8.64%37.02%-23.28%-27.80%
EBT Margin Growth (1y) -0.04M
EBT Margin (QoQ) 0.10M0.02M-0.23M0.08M
EBT (QoQ) -113.66%52.19%-20.92%12.04%-23.86%6.42%-25.35%
Enterprise Value Growth (1y) -790.41%24.86%29.74%52.30%73.84%-91.24%
Enterprise Value (QoQ) -1,822.31%29.50%34.58%-0.43%-62.23%34.08%55.59%44.91%
EPS (Basic) Growth (1y) 83.75%87.63%23.08%-23,400.00%
EPS (Basic) (QoQ) -32.50%87.74%61.54%-160.00%-0.88%23.75%-11,650.00%
FCF Margin Growth (1y) 0.04M
FCF Margin (QoQ) 0.34M-0.23M-0.06M-0.00M
Free Cash Flow Growth (1y) 8.00%-4.27%12.77%-12.93%22.60%-61.43%
Free Cash Flow (QoQ) 5.19%-13.21%16.96%-3.21%-7.45%5.28%-7.51%29.26%
Gross Margin (QoQ) 0.00M
Gross Profit (QoQ) -50.02%
Net Cash Flow Growth (1y) 255.13%-69.59%12.77%-12.93%-171.43%326.48%
Net Cash Flow (QoQ) 2,334.01%-130.97%16.96%156.73%108.39%-188.85%-7.51%64.12%
Net Income Growth (1y) -8.64%37.02%-23.28%-27.80%
Net Income (QoQ) -113.66%52.19%-20.92%12.04%-23.86%6.42%-25.35%
Net Income towards Common Stockholders Growth (1y) 67.73%76.34%-23.62%-28.58%
Net Income towards Common Stockholders (QoQ) -68.69%82.15%-21.35%11.67%-23.66%6.74%-26.22%
Net Margin Growth (1y) 1.07M
Net Margin (QoQ) 0.58M0.63M-0.23M0.08M
Operating Income Growth (1y) -8.64%37.02%-23.28%-27.80%
Operating Income (QoQ) -113.66%52.19%-20.92%12.04%-23.86%6.42%-25.35%
Operating Margin Growth (1y) -0.04M
Operating Margin (QoQ) 0.10M0.02M-0.23M0.08M
Profit After Tax Growth (1y) 66.85%61.43%-23.62%-28.58%
Profit After Tax (QoQ) -6.28%70.90%-21.35%11.67%-23.66%6.74%-26.22%
Property, Plant & Equipment (Net) Growth (1y) 916.74%1,309.38%1,215.44%1,224.64%21.49%
Property, Plant & Equipment (Net) (QoQ) 30.22%5.23%-4.84%679.66%80.51%-1.78%-4.17%
Return on Assets Growth (1y) 8.00-20.0026.00
Return on Assets (QoQ) -2.0069.00-3.00-57.00-29.00
Return on Capital Employed Growth (1y) -18.00
Return on Capital Employed (QoQ) -33.00145.00-8.00-123.00
Return on Equity Growth (1y) -95.00-924.0013.00
Return on Equity (QoQ) -44.00144.00-4.00-191.00-873.00
Return on Sales Growth (1y) -376.00-0.00M-0.01M-0.02M
Return on Sales (QoQ) 956.00162.00-0.00M841.00-0.00M-0.01M-0.01M
Revenue Growth (1y) 0.57%
Revenue (QoQ) 168.35%-50.02%-26.88%2.56%
Share-based Compensation Growth (1y) -24.07%-60.15%-49.98%-28.64%25.48%163.45%
Share-based Compensation (QoQ) 716.55%-65.44%-28.90%-62.16%328.56%-56.62%1.43%-33.46%
Shareholder's Equity Growth (1y) 118.20%0.90%-12.94%-51.39%-100.51%55.48%
Shareholder's Equity (QoQ) 129.29%-23.17%-42.51%40.69%62.37%-33.71%-67.90%-101.48%